KSE - Delayed Quote KRW

Hanmi Science Co., Ltd. (008930.KS)

32,750.00
0.00
(0.00%)
As of 1:42:39 PM GMT+9. Market Open.

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
NameTitlePayExercisedYear Born
Mr. Jong-Hoon Lim Chief Executive Officer -- -- 1961
Ms. Ju-Hyun Lim President & Inside Director -- -- 1974
Mr. Chan Seob Kim CFO & Senior MD -- -- 1965

Hanmi Science Co., Ltd.

14 Wiryeseong-daero
Songpa-gu
Seoul, 05545
South Korea
82 2 410 9114 https://www.hanmiscience.co.kr
Sector: 
Healthcare

Description

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.

Corporate Governance

Hanmi Science Co., Ltd.’s ISS Governance QualityScore as of May 1, 2025 is 5. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 8; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 28, 2025 at 10:59 AM UTC - August 1, 2025 at 12:00 PM UTC

Hanmi Science Co., Ltd. Earnings Date

Recent Events

December 27, 2024 at 12:00 AM UTC

Ex-Dividend Date